ホーム › 頭頸部がん › ニューヨーク › New York City
New York City、NYにおける頭頸部がんの臨床試験
New York Cityとその周辺地域（約30マイル以内）の拠点で、頭頸部がんに関する21件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
被験者募集中第1/2相
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
被験者募集中第2/3相
- Site #0155, New York
- Site#0142, New York
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
被験者募集中第2相
- Memorial Sloan Kettering Hospital, New York
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
被験者募集中第1相
- Icahn School of Medicine at Mt. Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
被験者募集中第1/2相
- Mount Sinai, New York
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center, New York
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
A Study of a New PET Scanner in People With Cancer
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center, New York
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center, New York
Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations
被験者募集中
- NYU Meyers College of Nursing, New York
- NYU Langone Perlmutter Cancer Center, New York
A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Brodalumab in the Treatment of Immune-Related Adverse Events
被験者募集中第1相
- Columbia University Irving Medical Center, New York
New MRI Biomarkers in Head and Neck Cancers
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center, New York
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
被験者募集中
- The New York Proton Center, New York
Impact of Photobiomodulation (PBM) on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer Patients
被験者募集中
- NYU Langone Health, New York
Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy
被験者募集中
- Weill Cornell Medicine, New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
被験者募集中第1/2相
- Weill Cornell Medicine, Cornell University (site 126), New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, New York
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
被験者募集中第1相
- Memorial Sloan Kettering, New York
- Columbia University Herbert Irving Comprehensive Cancer Center, New York
Comprehensive Outcomes for After Cancer Health
被験者募集中健康なボランティア歓迎
- Memorial Sloan Kettering Cancer Center, New York
他の都市における頭頸部がんの試験
- Houston, TX30件の研究
- Boston, MA22件の研究
- Nashville, TN21件の研究
- St. Louis, MO15件の研究
- Dallas, TX12件の研究
- Pittsburgh, PA11件の研究
- Los Angeles, CA10件の研究
- San Antonio, TX10件の研究
- Washington, DC10件の研究
- Baltimore, MD10件の研究
- Durham, NC10件の研究
- Chicago, IL10件の研究
New York Cityにおける他の研究
- 乳がん136件の研究
- 非小細胞肺癌121件の研究
- がん（全種類）109件の研究
- 前立腺がん103件の研究
- 転移性癌93件の研究
- 大腸癌78件の研究
- 卵巣がん69件の研究
- 肺がん60件の研究
- 多発性骨髄腫60件の研究
- 膵臓がん60件の研究
- 子宮内膜がん52件の研究
- 急性骨髄性白血病51件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。